FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074913624> ?p ?o ?g. }

• W2074913624 endingPage "1245" @default.
• W2074913624 startingPage "1240" @default.
• W2074913624 abstract "The objectives of the study were to assess the safety and pharmacokinetics of silodosin capsules in 82 healthy male Chinese subjects. To evaluate the safety after single-dosing escalation, 40 subjects were equally divided into 4 groups (2, 4, 8, 12 mg) by a randomized, double-blind and placebo-controlled design. To assess the pharmacokinetics after single-dosing, 30 subjects were equally divided into 3 groups (4, 8, 12 mg). To assess the safety and pharmacokinetics via multiple-dosing, 12 subjects were included as a group (4 mg once daily at day 1 and day 7; 4 mg twice daily at day 2 through day 6). The safety observations showed that mild adverse events, including postural hypotension, dizziness, and headache, were observed. After single-dosing at doses of 4, 8, and 12 mg, the mean area under the concentration-time curve from 0 to 36 h (AUC(0-36)) values were 136.82±46.38, 270.17±54.66, and 474.63±108.50 µg/l·h and the mean maximal silodosin concentration in plasma (C(max)) values were 26.70±7.48, 48.47±12.35, and 94.07±22.59 µg/l, respectively. After multiple-dosing, the C(max) value at day 7 was 33.84±19.54 µg/l, and the AUC(0-24) value at day 7 was 193.19±68.96 µg/l·h. The accumulation ratio of the AUC value was 1.55 by comparing the multiple-dosing with the single-dosing. It is concluded that silodosin is safe and tolerated in healthy Chinese male subjects at the dosing levels used in this study. The mean C(max) and AUC values of silodosin increased proportionally with dose escalation, showing characteristics of linear pharmacokinetics." @default.
• W2074913624 created "2016-06-24" @default.
• W2074913624 creator A5037101612 @default.
• W2074913624 creator A5041249182 @default.
• W2074913624 creator A5041509417 @default.
• W2074913624 creator A5065558630 @default.
• W2074913624 creator A5077426352 @default.
• W2074913624 creator A5082802691 @default.
• W2074913624 date "2011-01-01" @default.
• W2074913624 modified "2023-10-18" @default.
• W2074913624 title "Safety and Pharmacokinetic Studies of Silodosin, a New .ALPHA.1A-Adrenoceptor Selective Antagonist, in Healthy Chinese Male Subjects" @default.
• W2074913624 cites W1489169544 @default.
• W2074913624 cites W1971073617 @default.
• W2074913624 cites W1992790153 @default.
• W2074913624 cites W2004864554 @default.
• W2074913624 cites W2033685093 @default.
• W2074913624 cites W2035539636 @default.
• W2074913624 cites W2084573269 @default.
• W2074913624 cites W2087654797 @default.
• W2074913624 cites W2088114060 @default.
• W2074913624 cites W2158002048 @default.
• W2074913624 cites W2949275490 @default.
• W2074913624 cites W4236163484 @default.
• W2074913624 doi "https://doi.org/10.1248/bpb.34.1240" @default.
• W2074913624 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21804212" @default.
• W2074913624 hasPublicationYear "2011" @default.
• W2074913624 type Work @default.
• W2074913624 sameAs 2074913624 @default.
• W2074913624 citedByCount "14" @default.
• W2074913624 countsByYear W20749136242013 @default.
• W2074913624 countsByYear W20749136242015 @default.
• W2074913624 countsByYear W20749136242016 @default.
• W2074913624 countsByYear W20749136242017 @default.
• W2074913624 countsByYear W20749136242018 @default.
• W2074913624 countsByYear W20749136242019 @default.
• W2074913624 countsByYear W20749136242020 @default.
• W2074913624 countsByYear W20749136242023 @default.
• W2074913624 crossrefType "journal-article" @default.
• W2074913624 hasAuthorship W2074913624A5037101612 @default.
• W2074913624 hasAuthorship W2074913624A5041249182 @default.
• W2074913624 hasAuthorship W2074913624A5041509417 @default.
• W2074913624 hasAuthorship W2074913624A5065558630 @default.
• W2074913624 hasAuthorship W2074913624A5077426352 @default.
• W2074913624 hasAuthorship W2074913624A5082802691 @default.
• W2074913624 hasBestOaLocation W20749136241 @default.
• W2074913624 hasConcept C112705442 @default.
• W2074913624 hasConcept C121608353 @default.
• W2074913624 hasConcept C126322002 @default.
• W2074913624 hasConcept C126894567 @default.
• W2074913624 hasConcept C142724271 @default.
• W2074913624 hasConcept C170493617 @default.
• W2074913624 hasConcept C197934379 @default.
• W2074913624 hasConcept C204787440 @default.
• W2074913624 hasConcept C22979827 @default.
• W2074913624 hasConcept C27081682 @default.
• W2074913624 hasConcept C2776235491 @default.
• W2074913624 hasConcept C2776885963 @default.
• W2074913624 hasConcept C2777288759 @default.
• W2074913624 hasConcept C2779161064 @default.
• W2074913624 hasConcept C2779478474 @default.
• W2074913624 hasConcept C42219234 @default.
• W2074913624 hasConcept C71924100 @default.
• W2074913624 hasConcept C76318530 @default.
• W2074913624 hasConcept C98274493 @default.
• W2074913624 hasConceptScore W2074913624C112705442 @default.
• W2074913624 hasConceptScore W2074913624C121608353 @default.
• W2074913624 hasConceptScore W2074913624C126322002 @default.
• W2074913624 hasConceptScore W2074913624C126894567 @default.
• W2074913624 hasConceptScore W2074913624C142724271 @default.
• W2074913624 hasConceptScore W2074913624C170493617 @default.
• W2074913624 hasConceptScore W2074913624C197934379 @default.
• W2074913624 hasConceptScore W2074913624C204787440 @default.
• W2074913624 hasConceptScore W2074913624C22979827 @default.
• W2074913624 hasConceptScore W2074913624C27081682 @default.
• W2074913624 hasConceptScore W2074913624C2776235491 @default.
• W2074913624 hasConceptScore W2074913624C2776885963 @default.
• W2074913624 hasConceptScore W2074913624C2777288759 @default.
• W2074913624 hasConceptScore W2074913624C2779161064 @default.
• W2074913624 hasConceptScore W2074913624C2779478474 @default.
• W2074913624 hasConceptScore W2074913624C42219234 @default.
• W2074913624 hasConceptScore W2074913624C71924100 @default.
• W2074913624 hasConceptScore W2074913624C76318530 @default.
• W2074913624 hasConceptScore W2074913624C98274493 @default.
• W2074913624 hasIssue "8" @default.
• W2074913624 hasLocation W20749136241 @default.
• W2074913624 hasLocation W20749136242 @default.
• W2074913624 hasOpenAccess W2074913624 @default.
• W2074913624 hasPrimaryLocation W20749136241 @default.
• W2074913624 hasRelatedWork W111038150 @default.
• W2074913624 hasRelatedWork W2002994412 @default.
• W2074913624 hasRelatedWork W2051764329 @default.
• W2074913624 hasRelatedWork W2064759457 @default.
• W2074913624 hasRelatedWork W2074913624 @default.
• W2074913624 hasRelatedWork W2080969318 @default.
• W2074913624 hasRelatedWork W2098266057 @default.
• W2074913624 hasRelatedWork W2604484584 @default.
• W2074913624 hasRelatedWork W3207313530 @default.
• W2074913624 hasRelatedWork W4220955662 @default.

• next